Molipaxin is for the treatment of depression, mixed anxiety and depression.
Dosage and Directions for Use
The dosage is dependent upon the diagnosis and the severity of the condition and the individual patient's response. The daily dosage is usually administered in three divided doses.
Adults
Depression - The optimal dosage is between 300 - 400 mg/day. It is suggested that a starting dose of 150 mg/day is given for the first week, increasing to 300 mg/day or higher according to the clinical response (600 mg/day dosage has been reported).
Mixed anxiety and depression - The recommended starting dose is between 100 - 150 mg/day. When depression is the predominant symptom, a dose of 300 - 400 mg daily may be required to obtain a satisfactory response.
Children
Molipaxin is not recommended for use in children.
Contra-Indications
Combined use with other psychotropic drugs should only be undertaken with due recognition of the possibility of potentiation.
Pregnancy and lactation: The safety of Molipaxin in human pregnancy has not been established.
Side Effects and Special Precautions
Molipaxin should be administered with care to patients receiving barbiturates, muscle relaxants and volatile anaesthetics, since it has been shown to potentiate the action of these substances. Patients should be warned about the possibility of their judgement being impaired when handling dangerous machinery and when driving. The following side-effects have been noted: headache, dizziness, drowsiness, nausea and vomiting, weakness, decreased alertness, weight loss, tremor, dry mouth, tachycardia, constipation, diarrhoea, hypertension, blurred vision, excitement, restlessness, irritability, confusional states, insomnia, skin rashes and priapism.
Known symptoms of Overdosage and particulars of its treatment
There is no specific antidote to Molipaxin. The stomach should be emptied as quickly as possible and symptomatic and supportive therapy given.
Storage Instructions
Store in a cool, dry place, below 25°C
Protect from light.
Keep out of reach of children.
Foreign Brand Availability
- Azonz (Finland)
- Beneficat (Argentina)
- Bimaran (Argentina)
- Deprax (Spain)
- Depresil (Philippines)
- Depyrel (Israel)
- Desirel (Thailand)
- Manegan (Argentina)
- Molipaxin (England; Ireland; South-Africa)
- Pragmarel (France)
- Reslin (Japan)
- Taxagon (Argentina)
- Thombran (Germany)
- Trazodil (Israel)
- Trazolan (Belgium; India; Netherlands)
- Trazone (Indonesia; Portugal; Taiwan)
- Trittico (Austria; Colombia; Greece; Hong-Kong; Italy; Peru; Switzerland)
| 
